<img height="1" width="1" src="https://www.facebook.com/tr?id=414339248965737&amp;ev=PageView &amp;noscript=1">

Clinical Trial Solutions

Protect ocular endpoints with the only provider dedicated to point-of-need eye exams for clinical trials. 

With over 80% of US clinical trials failing to meet their patient enrollment timelines and an average of 30% of patients dropping out, point-of-need ophthalmic clinics are a game changer.

Quality Ocular Endpoint Protection

2020 Onsite Ophthalmic Clinical Trial Solutions

20/20 Onsite provides end-to-end mobile ophthalmic solutions that support every phase of your clinical trial. From protocol consultation and precision prescreening to enrollment acceleration and patient retention, our services are designed to integrate seamlessly into your workflow. As the only provider dedicated to point-of-need eye assessments for clinical trials, we help you meet the highest clinical research standards and protect your ocular endpoints.

✔ Advanced Ocular Assessments Delivered Nationwide
 ✔ Accelerated Enrollment, Zero Added Site Burden
 ✔ Stronger Retention by Meeting Patients Where They Are
 ✔ Effortless Integration into Your Trial Workflow

Point of Need

100%

Screening timelines met across all business operations.

Data Integrity

98%

Data accuracy submission rate.

Patient Retention

91%

Patient retention rate vs industry standard 70%.

Patient Centricity

95+

Patient Net Promotor Score vs industry average NPS of 30-50.

Watch how 20/20 Onsite supports clinical trials

The level of care that 20/20 Onsite provides to patients is outstanding in every way. The staff is professional, kind, and compassionate, and they are well-trained to handle any challenge that comes their way. I believe that mobile care is the cutting-edge of optometry, and I am honored to be a part of it. Dr. Keswani, OD
We recognize the incredible commitment patients make when they enroll in our trials and our goal is to match that commitment and support them in any way possible. By using a creative patient-focused approach to testing via 20/20 Onsite’s mobile vision testing program, we ‘take the test to the patient’ to support their needs during this extremely difficult time. Sue Washer, CEO, AGTC
While working with 20/20 Onsite for previous and current studies, we have been able to provide ophthalmological services that were previously not feasible for our clinical units. Doing so has been very successful in providing safety and ophthalmological oversight of study participants – as required by good clinical practices and the sponsor protocol. Dr. David Wyatt, Vice-President and Global Medical Lead, Syneos Health
It has been a pleasure to work with 20/20 Onsite. Your professionalism, attention to detail, and willingness to pivot or adjust to our sometimes fluid clinical trial protocol schedules has been such a blessing. We have certainly appreciated the opportunity to work with you; and anticipate future endeavors. Jerry Punch, MD. Co-Primary Investigator, Alliance for Multispecialty Research (AMR)

End-to-End Clinical Trial Solutions

2020 Onset Point of Need Ophthalmic Assessments for Clinical Trials - Clinical Trial Solultions and Capabilities-1

Study Design and Protocol Review

2020 Onsite Ophthalmic Clinical Trial Solutions Protocol Review

We ensure that every aspect of your study is aligned with its ocular endpoints, resulting in compliant trial designs that meet critical timelines and schedules. With a proven track record of refining protocols for numerous multi-center studies, we consistently improve clinical trial outcomes.

  • Expertly aligning ocular assessments with study endpoints to ensure compliant design and maintain timelines and schedules.
  • Tailoring patient recruitment and protocol strategies to enhance efficiency and safeguard trial success.
Protocol optimization | Endpoint alignment | Trial strategy and design | Compliance | Risk mitigation

Patient Prescreening

Our prescreening process harnesses advanced analytics and targeted outreach to identify candidates for your clinical study. By thoroughly evaluating patient profiles early on, we significantly reduce screening times (i.e., reduce SF rates by up to 60%) and ensure that only the best-fit participants move forward.

  • Utilizes data-driven insights to target and identify ideal candidates precisely.
  • Streamlines initial outreach and evaluation, reducing screening time and enhancing candidate suitability.
Data analytics | Profile evaluation | Candidate outreach | Point-of-need screening
2020 Onsite Ophthalmic Clinical Trial Solutions Patient Prescreening

Patient Enrollment

2020 Onsite Ophthalmic Clinical Trial Solutions Patient Enrollment

Our patient enrollment strategy is centered on creating a smooth and engaging enrollment process that minimizes barriers to entry. We combine point-of-need assessments with personalized support to efficiently enroll patients while strictly adhering to regulatory standards. 

  • Implements a user-friendly, patient-centric exam assessment schedule to improve patient engagement.
  • Ensures swift, compliant onboarding that accelerates the start of your clinical trial.
Protocol alignment | Patient Enrollment | Seamless integration | Point-of-need assessments

Seamless Exam Integration

Our integration model enables your clinical trial to incorporate ophthalmic assessments without disrupting established workflows. This integration reduces disruptions and maintains the integrity of critical data throughout the trial.

  • Synchronizes point-of-need vision clinics with established clinical workflows for seamless execution.
  • Optimizes exam workflows to ensure continuous, high-quality data collection and minimal process disruption.
Workflow coordination | Data integrity | Regulatory compliance | Process integration
2020 Onsite Ophthalmic Clinical Trial Solutions Exam Integration-1

Patient Retention

2020 Onsite Ophthalmic Clinical Trial Solutions Patient Retention

Our retention solutions are designed to keep patients engaged, informed, and motivated throughout the clinical journey. Our proactive strategies and educational tools help sustain engagement, building the trust required for long-term retention.

  • Employs proactive communication, scheduling, and follow-up strategies to sustain engagement.
  • Uses educational tools and support to foster a positive trial experience.
Proactive communication | Point-of-need support | Compliance focused | Patient centric

Post Marketing

Ensure that trial patients continue to receive the follow-up assessments required by your study, wherever they are. Our point-of-need assessments help analyze long-term outcomes to keep patient safety at the forefront.

  • Conducts comprehensive point-of-need assessments to evaluate real-world effectiveness and long-term outcomes.
  • Keep patient safety and compliance at the forefront with our point-of-need, flexible post-market solutions.
Real-world data | Regulatory compliance | Safety focused | Point-of-need assessments
2020 Onsite Ophthalmic Clinical Trial Solutions Post Marketing

Take a Tour

Tour our patient-centric, point-of-need Mobile Vision Clinic (MVC) and see how we accelerate clinical trials.

Clinical Trials Phase 1-3

Support for ophthalmic assessments or other study-specific eye-related solutions as part of a research protocol.

LEARN MORE

Post Marketing

Support for safety or surveillance ophthalmic assessments and eye-related clinical trial solutions for patients outside of a clinical protocol.

LEARN MORE
20/20 Onsite Ophthalmic assessments and eye-related clinical trial solutions - MVC

Mobile Vision Clinic

20/20 Onsite Ophthalmic assessments and eye-related clinical trial solutions - MVS

Mobile Vision Suite

20/20 Onsite Ophthalmic assessments and eye-related clinical trial solutions - MVP

Mobile Vision Pod

case_study

Applied Genetics Technology Company (AGTC) partners with 20/20 for their nationwide ophthalmic phase 1 and 2 clinical trials

READ CASE STUDY
press_release

Observational Study Confirms Eye Exams in Mobile Settings Have the Same Results as In-Office Exams

READ MORE
white_paper

Keeping Your Trials on Track: How Mobile Vision Clinics Are Making an Impact on Pre-screening, Screening and Retention

READ WHITEPAPER

Meet 20/20 Onsite's Industry and Scientific Advisory Board

The Industry and Scientific Advisory Board (IASAB) meets quarterly to help identify patient needs, product opportunities, and market challenges associated with the provision of vision-related assessments for clinical trials and safety surveillance.

Rajat-Agrawal-Headshot
Rajat Agrawal, MD, MS

CEO and President Retina Global

Headshot-Jeanne
Jeanne Hecht, Chair

Founder and CEO JTH Consulting, LLC

Jeffrey-S.-Heier-Headshot
Jeffrey S. Heier, MD

Director of the Vitreoretinal Service and Director of Retina Research Ophthalmic Consultants of Boston (OCB)

Peter Kaiser Headshot-1
Peter K. Kaiser, MD

Chaney Family Endowed Chair in Ophthalmology Research and Professor of Ophthalmology Cleveland Clinic Lerner College of Medicine

Beth-Marsh-Headshot
Beth Marsh

Vice President of North America Sales and Marketing, Ophthalmology Apellis Pharmaceuticals

Jason-Menzo-Headshot
Jason Menzo

Chief Operating Officer Foundation Fighting Blindness

Adam-Ramsey-Headshot
Adam Ramsey, OD

Owner Socialite Vision

Medical-Solution-1

Click below to read more about each board member's commitment to research or submit a question to be asked during our next quarterly meeting.

LEARN MORE ABOUT OUR IASAB AND THEIR VISION FOR INNOVATION

Benefits of Our Clinical Trial Solutions 

Point-of-Need Advanced Exams
 Collect high-quality, consistent data with advanced assessments, built to align seamlessly with your protocol. 

Improved Patient Retention 
Support long-term engagement by meeting patients where they are, removing travel barriers, and creating a more accessible trial experience. 

Faster Enrollment 
 Increase recruitment by bringing trials directly to patients, reducing logistical challenges, and maximizing participation rates. 

Reduced Trial Costs 
 Eliminate the need for permanent infrastructure and associated overhead, resulting in significant cost savings for each trial phase. 

Enhanced Flexibility 
 Expand the reach of your clinical trial solutions by conducting studies throughout the United States, improving geographic coverage and diversity. 

Timelines You Can Trust 
 Get ahead of schedule with streamlined operations that adapt to real-world demands, keeping your trials on time and on target. 
Point-of-Need Delivery

Mobile Vision Clinics (MVCs)

2020 Onsite Clinical Trial Solutions Mobile Vision Clinic (1)

Fully equipped clinics on wheels providing comprehensive ophthalmic assessments essentially anywhere, eliminating geographical barriers. 

  • MVCs are flexible solutions that eliminate geographical barriers and allow for point-of-need assessments, improving patient access and diversity for clinical trials.
  • MVCs have traveled over 200,000 miles across 48 states in the past year.

Mobile Vision Pods (MVPs)

2020 Onsite Clinical Trial Solutions Onsite Vision Pod

Semi-permanent exam spaces that can be set up and customized per study requirements. Can be deployed externally at sites for extended periods.

  • MVPs' customizable design allows them to fit in various spaces and be tailored to specific study requirements, offering a cost-effective and adaptable solution.
  • MVPs have been successfully deployed in multiple clinical trials, providing a dedicated and comfortable environment for on-site ophthalmic assessments.

Mobile Clinic Suites (MCSs)

2020 Onsite Clinical Trial Solutions Onsite Vision Suite

Portable solutions that bring ophthalmic equipment and certified staff to existing exam rooms and suitable facilities.

  • MCSs seamlessly integrate with existing clinic workflows and minimize disruption, making them ideal for sites with limited space or that require specific scheduling flexibility.
  • MCSs have been utilized to rescue clinical trials facing challenges with ophthalmic assessments. They ensure the timely completion of studies and data collection.

 

Comprehensive Ophthalmic Assessments

Our mobile vision clinics are equipped to provide a full suite of standardized, certified assessments that ensure data integrity, compliance, quality ocular endpoint protection, and patient comfort. Here are a few of the evaluations we routinely perform for clinical trials.

Assessments

Description

Equipment

Dilated Fundus Exam

Special eye drops dilate a person's pupils, making them more prominent so that light can be shined into the eyes to evaluate internal structures like the retina, macula, and optic nerve.

Binocular indirect ophthalmoscope and slit lamp, and 20D lens. Sometimes, a 90D/78D lens is needed for an additional look

Optical Coherence Tomography (OCT)

A special machine sends light into the eye to capture a scan of the retinal layers. These scans allow an eye doctor to identify specific retinal layers affected by various diseases.

Optical coherence tomography machine

BCVA

Best-corrected visual acuity (BCVA) measures the best possible vision in each eye using a prescription.

Visual Chart (Snellen, ETDRS) and Phoropter system or Trial Lenses

Slit Lamp Biomicroscopy

The eye doctor uses a special microscope to magnify and examine the front and internal structures of the eye, assessing eye health and detecting any diseases.

Slit lamp and 90D lens or 78D lens

Intraocular Pressure

Intraocular pressure measures the fluid pressure inside the eye. Maintaining this pressure within a healthy range is essential to prevent ocular conditions like glaucoma.

NCT OR Goldmann applanation tonometry on a slit lamp OR iCare tonometer

Fundus Photography

A special machine takes photos of the inside of the eye to assess structures like the retina, optic nerve, and macula. This photography can be used to monitor changes in the eyes over time.

AFC 330, Zeiss Clarus, Optos (many options)

Visual Field

A visual field test assesses a person's peripheral and central vision to detect vision loss or blind spots.

Humphrey Field or Virtual Visual Field

Color Vision

A color vision test measures a person's ability to see colors, specifically detecting deficiencies in distinguishing the most common colors, yellow/blue, and red/green.

Ishihara test

Ocular Motility

Ocular motility testing evaluates the function of eye muscles and the ability to move the eyes in various directions. It is beneficial for diagnosing binocular vision issues.

Usually done with a transilluminator or pen light

Pupil Testing

Pupil testing involves directing lights at a subject’s pupils to assess for normal reactions in each eye and between the eyes.

Usually done with a transilluminator or pen light

 

Clinical Case Studies
2020 Onsite Ophthalmic Clinical Trial Solutions

Streamlining a Clinical Study for Syneos Health

2020 Onsite Ophthalmic Clinical Trial Solutions

Enhancing Phase 1 Clinical Trials with Point-of-Need Safety Assessments

2020 Onsite Ophthalmic Clinical Trial Solutions

Optimizing Non-Ophthalmic Phase 3 Trials with Point-of-Need Eye Assessments

20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Vertex
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Biogen
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Syneos
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Pega
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients AGTC
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Blue Bird Bio
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients Boston Public Schools
20/20 Onsite Point-of-need clinical trial ophthalmic assessments and solutions - Clients City of Boston
20/20 Onsite vs the Alternatives
2020 Onsite Ophthalmic Clinical Trial Solutions

FAQs: 20/20 Onsite's Clinical Trial Solutions

Book a call today to ensure trials stay on track with the only provider dedicated to point-of-need eye assessments for clinical research.

SIGN UP: EYES ON RESEARCH

Our newsletter dedicated to clinical research, insights on patient-centric treatments, and point-of-need clinical trial solutions.

Copyright © 2025.  | Privacy Policy